These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1012 related items for PubMed ID: 15118656

  • 1. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP.
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [Abstract] [Full Text] [Related]

  • 2. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [Abstract] [Full Text] [Related]

  • 3. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [Abstract] [Full Text] [Related]

  • 4. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Estrogen with and without progestin: benefits and risks of short-term use.
    LaCroix AZ.
    Am J Med; 2005 Dec 19; 118 Suppl 12B():79-87. PubMed ID: 16414331
    [Abstract] [Full Text] [Related]

  • 11. [What scientific and clinical findings will result from the controlled trial "Women's Health Initiative"?].
    Gaspard U.
    Bull Mem Acad R Med Belg; 2003 Dec 19; 158(1-2):133-41; discussion 141-5. PubMed ID: 12852099
    [Abstract] [Full Text] [Related]

  • 12. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
    Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, Women's Health Initiative Investigators.
    Am J Epidemiol; 2005 Sep 01; 162(5):404-14. PubMed ID: 16033876
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA, Blake JM, Crosignani PG.
    Hum Reprod Update; 2005 Sep 01; 11(6):545-60. PubMed ID: 16150813
    [Abstract] [Full Text] [Related]

  • 20. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F.
    J Steroid Biochem Mol Biol; 2014 Jul 01; 142():4-11. PubMed ID: 24172877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.